Hint mode is switched on Switch off
For swift navigation between sections

Promomed
TIN 9702034818, PSRN 1217700349459

Organization name
Promomed PJSC
Country name
Russia
Country of registration
Russia
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

PJSC Promomed is a biopharmaceutical company, whose portfolio includes blockbuster drugs and biotechnological drugs that have no analogues on the Russian market.
PJSC Promomed was established in 2021 in Moscow.
The company's structure includes an R&D Center and the Biochemist plant. Thanks to this, Promomed implements the concept of a full production cycle. Promomed products are included in the state list of vital and essential medicines (VED).

Awards

Documentation

IFRS/US GAAP reports

2025
2024
2023
2022
2021
Show more Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Codes

  • TIN
    9702034818
  • NACE
    *** ***
  • NAICS
    *** ***
  • IEC
    770201001
  • PSRN
    1217700349459 on 26/07/2021
  • OKPO
    53098192

Issuer's quarterly reports/RAS Reports

2026
2025
2024
2023
2022
2021
Show more Hide
Authorization required
You need to request access

Annual reports

2025
2024
Show more Hide
Authorization required
You need to request access
Registration is required to get access.